FIVE PRIME THERAPEUTICS INC's ticker is and the CUSIP is 33830X954. A total of 2 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $0 | -100.0% | 258 | +16.2% | 0.00% | – |
| Q4 2020 | $377,000 | +2256.2% | 222 | +516.7% | 0.00% | – |
| Q4 2019 | $16,000 | -38.5% | 36 | -47.1% | 0.00% | – |
| Q3 2019 | $26,000 | +333.3% | 68 | +580.0% | 0.00% | – |
| Q2 2019 | $6,000 | -88.7% | 10 | -75.0% | 0.00% | – |
| Q1 2019 | $53,000 | +178.9% | 40 | +90.5% | 0.00% | – |
| Q4 2018 | $19,000 | +216.7% | 21 | +320.0% | 0.00% | – |
| Q3 2018 | $6,000 | -33.3% | 5 | -16.7% | 0.00% | – |
| Q2 2018 | $9,000 | -66.7% | 6 | -76.9% | 0.00% | -100.0% |
| Q1 2018 | $27,000 | +145.5% | 26 | +100.0% | 0.00% | – |
| Q4 2017 | $11,000 | +450.0% | 13 | -85.9% | 0.00% | – |
| Q3 2017 | $2,000 | -92.9% | 92 | +268.0% | 0.00% | -100.0% |
| Q1 2017 | $28,000 | +2700.0% | 25 | +1150.0% | 0.00% | – |
| Q4 2016 | $1,000 | – | 2 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 2 | -94.7% | 0.00% | -100.0% |
| Q2 2016 | $8,000 | +300.0% | 38 | +81.0% | 0.00% | – |
| Q1 2016 | $2,000 | +100.0% | 21 | -63.2% | 0.00% | – |
| Q4 2015 | $1,000 | -96.9% | 57 | +14.0% | 0.00% | -100.0% |
| Q3 2015 | $32,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|